Acelyrin CEO Mina Kim and Alumis CEO Martin Babler
Before Alumis went public via IPO, it tried doing a reverse merger with Acelyrin
Last month’s all-stock merger proposal between Alumis and Acelyrin wasn’t the first time the companies considered a deal.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
